The Greehey Children’s Cancer Research Institute and UT Health San Antonio are proud to recognize Weixing Zhao, PhD, as a recipient of the prestigious Michael Fry Award, honoring outstanding early-career contributions to radiation research.
Advancing Our Understanding of DNA Repair and Cancer Therapy
Dr. Zhao serves as an Associate Professor in the Department of Biochemistry and Structural Biology and holds a joint appointment at the Greehey Children’s Cancer Research Institute at UT Health San Antonio. His research focuses on the molecular mechanisms that govern how cells respond to DNA damage—an area central to both cancer development and treatment.
At the heart of his work is the study of DNA damage response pathways, particularly those involving the well-known tumor suppressor genes BRCA1 and BRCA2. His laboratory investigates how cells repair double-strand DNA breaks, manage replication stress, and maintain genome stability—processes that are critical for preventing cancer and influencing how tumors respond to therapy.
Using a combination of biochemistry, cell biology, and in vivo models, Dr. Zhao and his team aim to uncover why some cancers become resistant to radiation therapy and how these vulnerabilities can be targeted. Ultimately, this research holds promise for improving radiation-based therapies and developing more effective combination treatment strategies for cancer patients.
About the Michael Fry Award
The Michael Fry Award recognizes an individual early in their career who has demonstrated exceptional achievements in radiation research. While not defined by a strict age limit, recipients are typically within 10 years of completing their training, such as postdoctoral work, residency, or fellowship.
The award highlights significant contributions across areas of radiation science and aims to support and elevate emerging leaders whose work is shaping the future of cancer research and treatment.